Skip to content

Go back to News

Biotech Startup Acelyrin Buys Drugmaker ValenzaBio in Stock Deal

Acelyrin said it acquired privately held ValenzaBio in an all-stock transaction but didn’t disclose further financial details of the acquisition.

January 5, 2023

acylerin

Related News

See All News

Latigo Collects $150M to Get Non-Opioid Data to Compete with Vertex in Acute Pain

Biotechnology

March 17, 2025

Latigo Collects $150M to Get Non-Opioid Data to Compete with Vertex in Acute Pain

Perfuse Therapeutics Announces Positive Visual, Structural and Safety Data from a Ph1/2a Trial of PER-001 in Glaucoma Patients at the American Glaucoma Society Meeting

Biotechnology

March 3, 2025

Perfuse Therapeutics Announces Positive Visual, Structural and Safety Data from a Ph1/2a Trial of PER-001 in Glaucoma Patients at the American Glaucoma Society Meeting

Upstream Swells IPO to $255M as it Prepares to Join Nasdaq Along with CAMP4

Biotechnology

October 11, 2024

Upstream Swells IPO to $255M as it Prepares to Join Nasdaq Along with CAMP4